ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pimavanserin Market Insights, Forecast to 2029
Published Date: September 2023
|
Report Code: QYRE-Auto-21U15362
Home | Market Reports | Health| Aging & Geriatrics
Global Pimavanserin Market Insights Forecast to 2029
BUY CHAPTERS

Global Pimavanserin Market Insights, Forecast to 2029

Code: QYRE-Auto-21U15362
Report
September 2023
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
TEVA
MSN Laboratories
Zydus Lifesciences
ACADIA Pharmaceuticals

Pimavanserin Market

 It is an atypical antipsychotic which is approved for the treatment of Parkinson's disease psychosis and is also being studied for the treatment of Alzheimer’s disease psychosis
The global Pimavanserin market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pimavanserin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Pimavanserin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Pimavanserin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Pimavanserin include MSN Laboratories, Teva, Zydus Lifesciences and Acadia Pharmaceuticals, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes:

This report presents an overview of global market for Pimavanserin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Pimavanserin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pimavanserin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pimavanserin sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Pimavanserin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Pimavanserin sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including MSN Laboratories, Teva, Zydus Lifesciences and Acadia Pharmaceuticals, etc.

Scope of Pimavanserin Market Report

Report Metric Details
Report Name Pimavanserin Market
Segment by Type
  • 10Mg
  • 17Mg
  • 34Mg
Segment by Application
  • Hospital
  • Clinic
  • Other
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company MSN Laboratories, Teva, Zydus Lifesciences, Acadia Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Pimavanserin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Pimavanserin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
  • Chapter 8: China by type, by application sales and revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pimavanserin sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pimavanserin Market report?

Ans: The main players in the Pimavanserin Market are MSN Laboratories, Teva, Zydus Lifesciences, Acadia Pharmaceuticals

What are the Application segmentation covered in the Pimavanserin Market report?

Ans: The Applications covered in the Pimavanserin Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Pimavanserin Market report?

Ans: The Types covered in the Pimavanserin Market report are 10Mg, 17Mg, 34Mg

1 Study Coverage
1.1 Pimavanserin Product Introduction
1.2 Market by Type
1.2.1 Global Pimavanserin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 10Mg
1.2.3 17Mg
1.2.4 34Mg
1.3 Market by Application
1.3.1 Global Pimavanserin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pimavanserin Sales Estimates and Forecasts 2018-2029
2.2 Global Pimavanserin Revenue by Region
2.2.1 Global Pimavanserin Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Pimavanserin Revenue by Region (2018-2023)
2.2.3 Global Pimavanserin Revenue by Region (2024-2029)
2.2.4 Global Pimavanserin Revenue Market Share by Region (2018-2029)
2.3 Global Pimavanserin Sales Estimates and Forecasts 2018-2029
2.4 Global Pimavanserin Sales by Region
2.4.1 Global Pimavanserin Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Pimavanserin Sales by Region (2018-2023)
2.4.3 Global Pimavanserin Sales by Region (2024-2029)
2.4.4 Global Pimavanserin Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pimavanserin Sales by Manufacturers
3.1.1 Global Pimavanserin Sales by Manufacturers (2018-2023)
3.1.2 Global Pimavanserin Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pimavanserin in 2022
3.2 Global Pimavanserin Revenue by Manufacturers
3.2.1 Global Pimavanserin Revenue by Manufacturers (2018-2023)
3.2.2 Global Pimavanserin Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Pimavanserin Revenue in 2022
3.3 Global Key Players of Pimavanserin, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Pimavanserin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pimavanserin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pimavanserin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pimavanserin, Product Offered and Application
3.8 Global Key Manufacturers of Pimavanserin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pimavanserin Sales by Type
4.1.1 Global Pimavanserin Historical Sales by Type (2018-2023)
4.1.2 Global Pimavanserin Forecasted Sales by Type (2024-2029)
4.1.3 Global Pimavanserin Sales Market Share by Type (2018-2029)
4.2 Global Pimavanserin Revenue by Type
4.2.1 Global Pimavanserin Historical Revenue by Type (2018-2023)
4.2.2 Global Pimavanserin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Pimavanserin Revenue Market Share by Type (2018-2029)
4.3 Global Pimavanserin Price by Type
4.3.1 Global Pimavanserin Price by Type (2018-2023)
4.3.2 Global Pimavanserin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Pimavanserin Sales by Application
5.1.1 Global Pimavanserin Historical Sales by Application (2018-2023)
5.1.2 Global Pimavanserin Forecasted Sales by Application (2024-2029)
5.1.3 Global Pimavanserin Sales Market Share by Application (2018-2029)
5.2 Global Pimavanserin Revenue by Application
5.2.1 Global Pimavanserin Historical Revenue by Application (2018-2023)
5.2.2 Global Pimavanserin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Pimavanserin Revenue Market Share by Application (2018-2029)
5.3 Global Pimavanserin Price by Application
5.3.1 Global Pimavanserin Price by Application (2018-2023)
5.3.2 Global Pimavanserin Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Pimavanserin Market Size by Type
6.1.1 US & Canada Pimavanserin Sales by Type (2018-2029)
6.1.2 US & Canada Pimavanserin Revenue by Type (2018-2029)
6.2 US & Canada Pimavanserin Market Size by Application
6.2.1 US & Canada Pimavanserin Sales by Application (2018-2029)
6.2.2 US & Canada Pimavanserin Revenue by Application (2018-2029)
6.3 US & Canada Pimavanserin Market Size by Country
6.3.1 US & Canada Pimavanserin Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Pimavanserin Sales by Country (2018-2029)
6.3.3 US & Canada Pimavanserin Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pimavanserin Market Size by Type
7.1.1 Europe Pimavanserin Sales by Type (2018-2029)
7.1.2 Europe Pimavanserin Revenue by Type (2018-2029)
7.2 Europe Pimavanserin Market Size by Application
7.2.1 Europe Pimavanserin Sales by Application (2018-2029)
7.2.2 Europe Pimavanserin Revenue by Application (2018-2029)
7.3 Europe Pimavanserin Market Size by Country
7.3.1 Europe Pimavanserin Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Pimavanserin Sales by Country (2018-2029)
7.3.3 Europe Pimavanserin Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pimavanserin Market Size
8.1.1 China Pimavanserin Sales (2018-2029)
8.1.2 China Pimavanserin Revenue (2018-2029)
8.2 China Pimavanserin Market Size by Application
8.2.1 China Pimavanserin Sales by Application (2018-2029)
8.2.2 China Pimavanserin Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Pimavanserin Market Size by Type
9.1.1 Asia Pimavanserin Sales by Type (2018-2029)
9.1.2 Asia Pimavanserin Revenue by Type (2018-2029)
9.2 Asia Pimavanserin Market Size by Application
9.2.1 Asia Pimavanserin Sales by Application (2018-2029)
9.2.2 Asia Pimavanserin Revenue by Application (2018-2029)
9.3 Asia Pimavanserin Sales by Region
9.3.1 Asia Pimavanserin Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Pimavanserin Revenue by Region (2018-2029)
9.3.3 Asia Pimavanserin Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pimavanserin Market Size by Type
10.1.1 Middle East, Africa and Latin America Pimavanserin Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Pimavanserin Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Pimavanserin Market Size by Application
10.2.1 Middle East, Africa and Latin America Pimavanserin Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Pimavanserin Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Pimavanserin Sales by Country
10.3.1 Middle East, Africa and Latin America Pimavanserin Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Pimavanserin Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Pimavanserin Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 MSN Laboratories
11.1.1 MSN Laboratories Company Information
11.1.2 MSN Laboratories Overview
11.1.3 MSN Laboratories Pimavanserin Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 MSN Laboratories Pimavanserin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 MSN Laboratories Recent Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Overview
11.2.3 Teva Pimavanserin Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Teva Pimavanserin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Zydus Lifesciences
11.3.1 Zydus Lifesciences Company Information
11.3.2 Zydus Lifesciences Overview
11.3.3 Zydus Lifesciences Pimavanserin Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Zydus Lifesciences Pimavanserin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zydus Lifesciences Recent Developments
11.4 Acadia Pharmaceuticals
11.4.1 Acadia Pharmaceuticals Company Information
11.4.2 Acadia Pharmaceuticals Overview
11.4.3 Acadia Pharmaceuticals Pimavanserin Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Acadia Pharmaceuticals Pimavanserin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Acadia Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pimavanserin Industry Chain Analysis
12.2 Pimavanserin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pimavanserin Production Mode & Process
12.4 Pimavanserin Sales and Marketing
12.4.1 Pimavanserin Sales Channels
12.4.2 Pimavanserin Distributors
12.5 Pimavanserin Customers
13 Market Dynamics
13.1 Pimavanserin Industry Trends
13.2 Pimavanserin Market Drivers
13.3 Pimavanserin Market Challenges
13.4 Pimavanserin Market Restraints
14 Key Findings in The Global Pimavanserin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
TEVA
MSN Laboratories
Zydus Lifesciences
ACADIA Pharmaceuticals
List of Tables
    Table 1. Global Pimavanserin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Table 2. Major Manufacturers of 10Mg
    Table 3. Major Manufacturers of 17Mg
    Table 4. Major Manufacturers of 34Mg
    Table 5. Global Pimavanserin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Table 6. Global Pimavanserin Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. Global Pimavanserin Revenue by Region (2018-2023) & (US$ Million)
    Table 8. Global Pimavanserin Revenue by Region (2024-2029) & (US$ Million)
    Table 9. Global Pimavanserin Revenue Market Share by Region (2018-2023)
    Table 10. Global Pimavanserin Revenue Market Share by Region (2024-2029)
    Table 11. Global Pimavanserin Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 12. Global Pimavanserin Sales by Region (2018-2023) & (Box)
    Table 13. Global Pimavanserin Sales by Region (2024-2029) & (Box)
    Table 14. Global Pimavanserin Sales Market Share by Region (2018-2023)
    Table 15. Global Pimavanserin Sales Market Share by Region (2024-2029)
    Table 16. Global Pimavanserin Sales by Manufacturers (2018-2023) & (Box)
    Table 17. Global Pimavanserin Sales Share by Manufacturers (2018-2023)
    Table 18. Global Pimavanserin Revenue by Manufacturers (2018-2023) & (US$ Million)
    Table 19. Global Pimavanserin Revenue Share by Manufacturers (2018-2023)
    Table 20. Global Key Players of Pimavanserin, Industry Ranking, 2021 VS 2022 VS 2023
    Table 21. Pimavanserin Price by Manufacturers 2018-2023 (US$/Box)
    Table 22. Global Pimavanserin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Pimavanserin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pimavanserin as of 2022)
    Table 24. Global Key Manufacturers of Pimavanserin, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Pimavanserin, Product Offered and Application
    Table 26. Global Key Manufacturers of Pimavanserin, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Pimavanserin Sales by Type (2018-2023) & (Box)
    Table 29. Global Pimavanserin Sales by Type (2024-2029) & (Box)
    Table 30. Global Pimavanserin Sales Share by Type (2018-2023)
    Table 31. Global Pimavanserin Sales Share by Type (2024-2029)
    Table 32. Global Pimavanserin Revenue by Type (2018-2023) & (US$ Million)
    Table 33. Global Pimavanserin Revenue by Type (2024-2029) & (US$ Million)
    Table 34. Global Pimavanserin Revenue Share by Type (2018-2023)
    Table 35. Global Pimavanserin Revenue Share by Type (2024-2029)
    Table 36. Pimavanserin Price by Type (2018-2023) & (US$/Box)
    Table 37. Global Pimavanserin Price Forecast by Type (2024-2029) & (US$/Box)
    Table 38. Global Pimavanserin Sales by Application (2018-2023) & (Box)
    Table 39. Global Pimavanserin Sales by Application (2024-2029) & (Box)
    Table 40. Global Pimavanserin Sales Share by Application (2018-2023)
    Table 41. Global Pimavanserin Sales Share by Application (2024-2029)
    Table 42. Global Pimavanserin Revenue by Application (2018-2023) & (US$ Million)
    Table 43. Global Pimavanserin Revenue by Application (2024-2029) & (US$ Million)
    Table 44. Global Pimavanserin Revenue Share by Application (2018-2023)
    Table 45. Global Pimavanserin Revenue Share by Application (2024-2029)
    Table 46. Pimavanserin Price by Application (2018-2023) & (US$/Box)
    Table 47. Global Pimavanserin Price Forecast by Application (2024-2029) & (US$/Box)
    Table 48. US & Canada Pimavanserin Sales by Type (2018-2023) & (Box)
    Table 49. US & Canada Pimavanserin Sales by Type (2024-2029) & (Box)
    Table 50. US & Canada Pimavanserin Revenue by Type (2018-2023) & (US$ Million)
    Table 51. US & Canada Pimavanserin Revenue by Type (2024-2029) & (US$ Million)
    Table 52. US & Canada Pimavanserin Sales by Application (2018-2023) & (Box)
    Table 53. US & Canada Pimavanserin Sales by Application (2024-2029) & (Box)
    Table 54. US & Canada Pimavanserin Revenue by Application (2018-2023) & (US$ Million)
    Table 55. US & Canada Pimavanserin Revenue by Application (2024-2029) & (US$ Million)
    Table 56. US & Canada Pimavanserin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 57. US & Canada Pimavanserin Revenue by Country (2018-2023) & (US$ Million)
    Table 58. US & Canada Pimavanserin Revenue by Country (2024-2029) & (US$ Million)
    Table 59. US & Canada Pimavanserin Sales by Country (2018-2023) & (Box)
    Table 60. US & Canada Pimavanserin Sales by Country (2024-2029) & (Box)
    Table 61. Europe Pimavanserin Sales by Type (2018-2023) & (Box)
    Table 62. Europe Pimavanserin Sales by Type (2024-2029) & (Box)
    Table 63. Europe Pimavanserin Revenue by Type (2018-2023) & (US$ Million)
    Table 64. Europe Pimavanserin Revenue by Type (2024-2029) & (US$ Million)
    Table 65. Europe Pimavanserin Sales by Application (2018-2023) & (Box)
    Table 66. Europe Pimavanserin Sales by Application (2024-2029) & (Box)
    Table 67. Europe Pimavanserin Revenue by Application (2018-2023) & (US$ Million)
    Table 68. Europe Pimavanserin Revenue by Application (2024-2029) & (US$ Million)
    Table 69. Europe Pimavanserin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 70. Europe Pimavanserin Revenue by Country (2018-2023) & (US$ Million)
    Table 71. Europe Pimavanserin Revenue by Country (2024-2029) & (US$ Million)
    Table 72. Europe Pimavanserin Sales by Country (2018-2023) & (Box)
    Table 73. Europe Pimavanserin Sales by Country (2024-2029) & (Box)
    Table 74. China Pimavanserin Sales by Type (2018-2023) & (Box)
    Table 75. China Pimavanserin Sales by Type (2024-2029) & (Box)
    Table 76. China Pimavanserin Revenue by Type (2018-2023) & (US$ Million)
    Table 77. China Pimavanserin Revenue by Type (2024-2029) & (US$ Million)
    Table 78. China Pimavanserin Sales by Application (2018-2023) & (Box)
    Table 79. China Pimavanserin Sales by Application (2024-2029) & (Box)
    Table 80. China Pimavanserin Revenue by Application (2018-2023) & (US$ Million)
    Table 81. China Pimavanserin Revenue by Application (2024-2029) & (US$ Million)
    Table 82. Asia Pimavanserin Sales by Type (2018-2023) & (Box)
    Table 83. Asia Pimavanserin Sales by Type (2024-2029) & (Box)
    Table 84. Asia Pimavanserin Revenue by Type (2018-2023) & (US$ Million)
    Table 85. Asia Pimavanserin Revenue by Type (2024-2029) & (US$ Million)
    Table 86. Asia Pimavanserin Sales by Application (2018-2023) & (Box)
    Table 87. Asia Pimavanserin Sales by Application (2024-2029) & (Box)
    Table 88. Asia Pimavanserin Revenue by Application (2018-2023) & (US$ Million)
    Table 89. Asia Pimavanserin Revenue by Application (2024-2029) & (US$ Million)
    Table 90. Asia Pimavanserin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 91. Asia Pimavanserin Revenue by Region (2018-2023) & (US$ Million)
    Table 92. Asia Pimavanserin Revenue by Region (2024-2029) & (US$ Million)
    Table 93. Asia Pimavanserin Sales by Region (2018-2023) & (Box)
    Table 94. Asia Pimavanserin Sales by Region (2024-2029) & (Box)
    Table 95. Middle East, Africa and Latin America Pimavanserin Sales by Type (2018-2023) & (Box)
    Table 96. Middle East, Africa and Latin America Pimavanserin Sales by Type (2024-2029) & (Box)
    Table 97. Middle East, Africa and Latin America Pimavanserin Revenue by Type (2018-2023) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Pimavanserin Revenue by Type (2024-2029) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Pimavanserin Sales by Application (2018-2023) & (Box)
    Table 100. Middle East, Africa and Latin America Pimavanserin Sales by Application (2024-2029) & (Box)
    Table 101. Middle East, Africa and Latin America Pimavanserin Revenue by Application (2018-2023) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Pimavanserin Revenue by Application (2024-2029) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Pimavanserin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 104. Middle East, Africa and Latin America Pimavanserin Revenue by Country (2018-2023) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Pimavanserin Revenue by Country (2024-2029) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Pimavanserin Sales by Country (2018-2023) & (Box)
    Table 107. Middle East, Africa and Latin America Pimavanserin Sales by Country (2024-2029) & (Box)
    Table 108. MSN Laboratories Company Information
    Table 109. MSN Laboratories Description and Major Businesses
    Table 110. MSN Laboratories Pimavanserin Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2023)
    Table 111. MSN Laboratories Pimavanserin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. MSN Laboratories Recent Developments
    Table 113. Teva Company Information
    Table 114. Teva Description and Major Businesses
    Table 115. Teva Pimavanserin Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2023)
    Table 116. Teva Pimavanserin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Teva Recent Developments
    Table 118. Zydus Lifesciences Company Information
    Table 119. Zydus Lifesciences Description and Major Businesses
    Table 120. Zydus Lifesciences Pimavanserin Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2023)
    Table 121. Zydus Lifesciences Pimavanserin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Zydus Lifesciences Recent Developments
    Table 123. Acadia Pharmaceuticals Company Information
    Table 124. Acadia Pharmaceuticals Description and Major Businesses
    Table 125. Acadia Pharmaceuticals Pimavanserin Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2023)
    Table 126. Acadia Pharmaceuticals Pimavanserin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Acadia Pharmaceuticals Recent Developments
    Table 128. Key Raw Materials Lists
    Table 129. Raw Materials Key Suppliers Lists
    Table 130. Pimavanserin Distributors List
    Table 131. Pimavanserin Customers List
    Table 132. Pimavanserin Market Trends
    Table 133. Pimavanserin Market Drivers
    Table 134. Pimavanserin Market Challenges
    Table 135. Pimavanserin Market Restraints
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pimavanserin Product Picture
    Figure 2. Global Pimavanserin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Pimavanserin Market Share by Type in 2022 & 2029
    Figure 4. 10Mg Product Picture
    Figure 5. 17Mg Product Picture
    Figure 6. 34Mg Product Picture
    Figure 7. Global Pimavanserin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 8. Global Pimavanserin Market Share by Application in 2022 & 2029
    Figure 9. Hospital
    Figure 10. Clinic
    Figure 11. Other
    Figure 12. Pimavanserin Report Years Considered
    Figure 13. Global Pimavanserin Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Pimavanserin Revenue 2018-2029 (US$ Million)
    Figure 15. Global Pimavanserin Revenue Market Share by Region in Percentage: 2022 Versus 2029
    Figure 16. Global Pimavanserin Revenue Market Share by Region (2018-2029)
    Figure 17. Global Pimavanserin Sales 2018-2029 ((Box)
    Figure 18. Global Pimavanserin Sales Market Share by Region (2018-2029)
    Figure 19. US & Canada Pimavanserin Sales YoY (2018-2029) & (Box)
    Figure 20. US & Canada Pimavanserin Revenue YoY (2018-2029) & (US$ Million)
    Figure 21. Europe Pimavanserin Sales YoY (2018-2029) & (Box)
    Figure 22. Europe Pimavanserin Revenue YoY (2018-2029) & (US$ Million)
    Figure 23. China Pimavanserin Sales YoY (2018-2029) & (Box)
    Figure 24. China Pimavanserin Revenue YoY (2018-2029) & (US$ Million)
    Figure 25. Asia (excluding China) Pimavanserin Sales YoY (2018-2029) & (Box)
    Figure 26. Asia (excluding China) Pimavanserin Revenue YoY (2018-2029) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Pimavanserin Sales YoY (2018-2029) & (Box)
    Figure 28. Middle East, Africa and Latin America Pimavanserin Revenue YoY (2018-2029) & (US$ Million)
    Figure 29. The Pimavanserin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
    Figure 30. The Top 5 and 10 Largest Manufacturers of Pimavanserin in the World: Market Share by Pimavanserin Revenue in 2022
    Figure 31. Global Pimavanserin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 32. Global Pimavanserin Sales Market Share by Type (2018-2029)
    Figure 33. Global Pimavanserin Revenue Market Share by Type (2018-2029)
    Figure 34. Global Pimavanserin Sales Market Share by Application (2018-2029)
    Figure 35. Global Pimavanserin Revenue Market Share by Application (2018-2029)
    Figure 36. US & Canada Pimavanserin Sales Market Share by Type (2018-2029)
    Figure 37. US & Canada Pimavanserin Revenue Market Share by Type (2018-2029)
    Figure 38. US & Canada Pimavanserin Sales Market Share by Application (2018-2029)
    Figure 39. US & Canada Pimavanserin Revenue Market Share by Application (2018-2029)
    Figure 40. US & Canada Pimavanserin Revenue Share by Country (2018-2029)
    Figure 41. US & Canada Pimavanserin Sales Share by Country (2018-2029)
    Figure 42. U.S. Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 43. Canada Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 44. Europe Pimavanserin Sales Market Share by Type (2018-2029)
    Figure 45. Europe Pimavanserin Revenue Market Share by Type (2018-2029)
    Figure 46. Europe Pimavanserin Sales Market Share by Application (2018-2029)
    Figure 47. Europe Pimavanserin Revenue Market Share by Application (2018-2029)
    Figure 48. Europe Pimavanserin Revenue Share by Country (2018-2029)
    Figure 49. Europe Pimavanserin Sales Share by Country (2018-2029)
    Figure 50. Germany Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 51. France Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 52. U.K. Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 53. Italy Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 54. Russia Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 55. China Pimavanserin Sales Market Share by Type (2018-2029)
    Figure 56. China Pimavanserin Revenue Market Share by Type (2018-2029)
    Figure 57. China Pimavanserin Sales Market Share by Application (2018-2029)
    Figure 58. China Pimavanserin Revenue Market Share by Application (2018-2029)
    Figure 59. Asia Pimavanserin Sales Market Share by Type (2018-2029)
    Figure 60. Asia Pimavanserin Revenue Market Share by Type (2018-2029)
    Figure 61. Asia Pimavanserin Sales Market Share by Application (2018-2029)
    Figure 62. Asia Pimavanserin Revenue Market Share by Application (2018-2029)
    Figure 63. Asia Pimavanserin Revenue Share by Region (2018-2029)
    Figure 64. Asia Pimavanserin Sales Share by Region (2018-2029)
    Figure 65. Japan Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 66. South Korea Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 67. China Taiwan Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 68. Southeast Asia Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 69. India Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Pimavanserin Sales Market Share by Type (2018-2029)
    Figure 71. Middle East, Africa and Latin America Pimavanserin Revenue Market Share by Type (2018-2029)
    Figure 72. Middle East, Africa and Latin America Pimavanserin Sales Market Share by Application (2018-2029)
    Figure 73. Middle East, Africa and Latin America Pimavanserin Revenue Market Share by Application (2018-2029)
    Figure 74. Middle East, Africa and Latin America Pimavanserin Revenue Share by Country (2018-2029)
    Figure 75. Middle East, Africa and Latin America Pimavanserin Sales Share by Country (2018-2029)
    Figure 76. Brazil Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 77. Mexico Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 78. Turkey Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 79. Israel Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 80. GCC Countries Pimavanserin Revenue (2018-2029) & (US$ Million)
    Figure 81. Pimavanserin Value Chain
    Figure 82. Pimavanserin Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Blood-based Detection Kit for Early Diagnosis of Alzheimer's Disease Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-9Q17119
Tue Nov 11 00:00:00 UTC 2025

Add to Cart

Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-6P17247
Tue Nov 11 00:00:00 UTC 2025

Add to Cart

Global Alzheimer's Disease Blood Test Kit Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-22S16677
Mon Nov 10 00:00:00 UTC 2025

Add to Cart

Global Rivastigmine API Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-5M17076
Fri Nov 07 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions